AJCN Tufts Nutrition Symposium, Boston & Online Sept 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sies, H.
Right arrow Articles by Kelm, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sies, H.
Right arrow Articles by Kelm, M.
Agricola
Right arrow Articles by Sies, H.
Right arrow Articles by Kelm, M.
American Journal of Clinical Nutrition, Vol. 81, No. 1, 304S-312S, January 2005
© 2005 American Society for Clinical Nutrition


DIETARY POLYPHENOLS AND HEALTH: PROCEEDINGS OF THE 1ST INTERNATIONAL CONFERENCE ON POLYPHENOLS AND HEALTH

Cocoa polyphenols and inflammatory mediators1,2,3,4

Helmut Sies, Tankred Schewe, Christian Heiss and Malte Kelm

1 From Institute for Biochemistry and Molecular Biology I (HS, TS, CH) and the Department of Medicine, Division of Cardiology, Pulmonary Diseases, and Angiology (CH, MK), Heinrich Heine University Düsseldorf, Düsseldorf, Germany

ABSTRACT

Cocoa products are sources of flavan-3-ols, which have attracted interest regarding cardiovascular health. This review provides a survey of our research on the effects of cocoa polyphenols on leukotriene and nitric oxide (NO) metabolism and on myeloperoxidase-induced modification of LDL. Because intake of flavonoid-rich chocolate by human subjects was reported to decrease the plasma concentrations of proinflammatory cysteinyl leukotrienes, we assessed whether cocoa polyphenols inhibited human 5-lipoxygenase, the key enzyme of leukotriene synthesis. (–)-Epicatechin and other cocoa flavan-3-ols proved to be inhibitory at the enzyme level. This action may confer antileukotriene action in vivo. In a double-blind crossover study, 20 individuals at risk for cardiovascular diseases received cocoa beverages with high or low contents of flavan-3-ols. NO-dependent, flow-mediated dilation of the brachial artery and concentrations of nitroso compounds in plasma were measured, and it was shown that ingestion of the high-flavanol coca drink but not the low-flavanol cocoa drink significantly increased plasma concentrations of nitroso compounds and flow-mediated dilation of the brachial artery. Therefore, ingested flavonoids may reverse endothelial dysfunction through enhancement of NO bioactivity. Oxidative modification of LDL appears to be crucial for atherogenesis, and one of the mediators is the proinflammatory proatherogenic enzyme myeloperoxidase. Micromolar concentrations of (–)-epicatechin or other flavonoids were found to suppress lipid peroxidation in LDL induced by myeloperoxidase in the presence of physiologically relevant concentrations of nitrite, an NO metabolite. Adverse effects of NO metabolites, such as nitrite and peroxynitrite, were thus attenuated.

Key Words: Antioxidants • arachidonic acid • atherogenesis • chocolate • cocoa • flavan-3-ols • flavonoids • flow-mediated dilation • inflammation • leukotrienes • lipoxygenase • LDL • myeloperoxidase • nitrite • nitrosothiols • peroxynitrite • procyanidins




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
J. Balzer, T. Rassaf, C. Heiss, P. Kleinbongard, T. Lauer, M. Merx, N. Heussen, H. B. Gross, C. L. Keen, H. Schroeter, et al.
Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial.
J. Am. Coll. Cardiol., June 3, 2008; 51(22): 2141 - 2149.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. R. Allen, L. Carson, C. Kwik-Uribe, E. M. Evans, and J. W. Erdman Jr
Daily Consumption of a Dark Chocolate Containing Flavanols and Added Sterol Esters Affects Cardiovascular Risk Factors in a Normotensive Population with Elevated Cholesterol
J. Nutr., April 1, 2008; 138(4): 725 - 731.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. J. Ignarro, M. L. Balestrieri, and C. Napoli
Nutrition, physical activity, and cardiovascular disease: An update
Cardiovasc Res, January 15, 2007; 73(2): 326 - 340.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Schroeter, C. Heiss, J. Balzer, P. Kleinbongard, C. L. Keen, N. K. Hollenberg, H. Sies, C. Kwik-Uribe, H. H. Schmitz, and M. Kelm
(-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans
PNAS, January 24, 2006; 103(4): 1024 - 1029.
[Abstract] [Full Text] [PDF]


Home page
Food Science and Technology InternationalHome page
R. M. Lamuela-Raventos, A. I. Romero-Perez, C. Andres-Lacueva, and A. Tornero
Review: Health Effects of Cocoa Flavonoids
Food Science and Technology International, June 1, 2005; 11(3): 159 - 176.
[Abstract] [PDF]


Home page
J. Nutr.Home page
H. Sies, W. Stahl, and A. Sevanian
Nutritional, Dietary and Postprandial Oxidative Stress
J. Nutr., May 1, 2005; 135(5): 969 - 972.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. Scalbert, I. T Johnson, and M. Saltmarsh
Polyphenols: antioxidants and beyond
Am. J. Clinical Nutrition, January 1, 2005; 81(1): 215S - 217S.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by The American Society for Nutrition